Aaron Kantoff's Net Worth

$1.38 Million

Estimate Recalculated Nov 1, 2024 10:48AM EST

Who is Aaron Kantoff

Aaron Kantoff has an estimated net worth of $1.38 Million. This is based on reported shares across multiple companies, which include Centessa Pharmaceuticals plc, Tourmaline Bio, Inc., and Avalo Therapeutics, Inc..

SEC CIK

Aaron Kantoff's CIK is 0001862734

Past Insider Trading and Trends

2023 was Aaron Kantoff's most active year for acquiring shares with 4 total transactions. Aaron Kantoff's most active month to acquire stocks was the month of September. 2021 saw Aaron Kantoff paying a total of $119,850.00 for 10,000 shares, this is the most they've acquired in one year.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Centessa Pharmaceuticals plc

Investor
Updated Nov 18, 2021
Form 4
20.00%
10.00K
$11.99
$119.85K
Nov 18, 2021
60.00K
Purchase
Nov 18
Form 3
May 27, 2021
50.00K
Showing 2 results

Tourmaline Bio, Inc.

Investor
Updated Jun 07, 2024
Form 4
10.00K
Jun 07, 2024
10.00K
Grant
Jun 05
Form 4
19.79%
7.50K
$11.86
$88.95K
Oct 26, 2023
45.39K
Purchase
Oct 24
Form 4
85.78K
Oct 23, 2023
85.78K
Grant
Oct 19 - Oct 23
Form 3
Oct 23, 2023
Showing 4 results

Avalo Therapeutics, Inc.

Investor
Updated Aug 14, 2024
Form 4
34.10K
Aug 14, 2024
34.10K
Grant
Aug 13
Form 3
Apr 03, 2024
Showing 2 results